journal article·2021-12-08

Facile Separation of PEGylated Liposomes Enabled by Anti-PEG scFv

Wenjing Tang, Zui Zhang, Cheng Li, Yuxiu Chu, Jun Qian, Tianlei Ying, Weiyue Lu, Changyou Zhan

Nano Letters· Volume 21· Issue 23
Publisher page

Abstract

PEGylated nanocarriers have gained increasing attention due to reduced toxicity and enhanced circulation compared with free drugs. According to guidances of drug regulatory departments worldwide, it is crucial to determine free and liposomal drug concentrations; however, the conventional used separation methods including dialysis, ultrafiltration, and solid-phase extraction (SPE) have drawbacks of time-consuming, drug leakage, environmental pollution or error bias of trace level drug. Here we developed a facile PEG-scFv-based separation method combined with HPLC to quantify free doxorubicin (DOX) and liposomal DOX in plasma. Anti-PEG single chain variable fragment antibody (PEG-scFv) was adopted to sediment PEGylated liposomes by simple incubation and low speed centrifugation. Compared to SPE, it demonstrated sufficient accuracy and sensitivity to evaluate free and liposomal DOX with intact liposomes. Therefore, it can serve as an alternative approach of SPE, which is suitable for quality assessment and pharmacokinetics evaluation of PEGylated liposomal drugs and possible other PEGylated nanocarriers.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Membrane Separation Technologies · Microfluidic and Capillary Electrophoresis Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

MOE Key Laboratory of Smart Drug Delivery, School of Pharmacy & State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai, 201203 P.R. China

Department of Pharmacology, School of Basic Medical Sciences & Center of Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University, Shanghai, 200032 P.R. China

Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences, Fudan University, Shanghai, 200032 PR China

Funding

Natural Science Foundation of Shanghai · National Natural Science Foundation of China · Shanghai Education commission major project

References (29)

Show source-provided references
1. 10.3390/molecules2523567210.3390/molecules25235672 ↗
2. 10.1248/bpb.b16-0062410.1248/bpb.b16-00624 ↗
3. 10.1021/acs.nanolett.1c0113310.1021/acs.nanolett.1c01133 ↗
4. 10.1073/pnas.88.24.1146010.1073/pnas.88.24.11460 ↗
5. 10.1016/j.addr.2015.09.01210.1016/j.addr.2015.09.012 ↗
6. 10.1016/j.addr.2021.04.01510.1016/j.addr.2021.04.015 ↗
7. 10.1016/j.jconrel.2012.03.02010.1016/j.jconrel.2012.03.020 ↗
8. 10.1016/j.addr.2012.09.03710.1016/j.addr.2012.09.037 ↗
9. 10.1016/j.ijpharm.2012.06.03010.1016/j.ijpharm.2012.06.030 ↗
10. 10.1126/science.371.6524.1010.1126/science.371.6524.10 ↗
11. 10.1200/JCO.2001.19.5.144410.1200/JCO.2001.19.5.1444 ↗
12. US Health and Human Services, F. a. D. A., Center for Drug Evaluation and Research (CDER). Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and: Bioavailability; and Labeling Documentation; US FDA, 2018.
13. Committee for Human Medicina Products (CHMP), E. m. a. E. Reflection paper on the data requirements for intravenous liposomal products developed with reference to an innovator liposomal product; EMA, 2013.
14. Adminstration (NMPA), N. M. P. Technical requirements for the consistency evaluation of quality and efficacy of chemical injections of generic drugs (special injections); NMPA, 2020.
15. 10.1016/j.jchromb.2017.11.02010.1016/j.jchromb.2017.11.020 ↗
16. 10.1007/978-1-4939-7352-1_1910.1007/978-1-4939-7352-1_19 ↗
17. 10.1002/elps.20130023710.1002/elps.201300237 ↗
18. 10.1002/1522-2683(200108)22:13<2782::AID-ELPS2782>3.0.CO;2-I10.1002/1522-2683(200108)22:13<2782::AID-ELPS2782>3.0.CO;2-I ↗
19. 10.2147/IJN.S1303110.2147/IJN.S13031 ↗
20. 10.1016/0003-2697(90)90528-H10.1016/0003-2697(90)90528-H ↗
21. 10.1016/j.jchromb.2016.06.00810.1016/j.jchromb.2016.06.008 ↗
22. Krishna, M.; Kozhich, A. T.; Corbett, M. J.; Lin, Z.; Piccoli, S. P. Antibodies to Polyethylene Glycol. US9804170 B2, Oct, 31, 2017.
23. 10.1016/j.jconrel.2020.12.04710.1016/j.jconrel.2020.12.047 ↗
24. 10.1080/17425247.2016.118248510.1080/17425247.2016.1182485 ↗
25. 10.1021/acs.nanolett.0c0480610.1021/acs.nanolett.0c04806 ↗
26. 10.1016/j.jconrel.2020.01.01810.1016/j.jconrel.2020.01.018 ↗
27. 10.1021/acsnano.9b0721810.1021/acsnano.9b07218 ↗
28. 10.1016/j.addr.2020.07.02410.1016/j.addr.2020.07.024 ↗
29. 10.1021/acs.analchem.6b0343710.1021/acs.analchem.6b03437 ↗